Borcherding, DC, Hugo, ER, Idelman, G, De Silva, A, Richtand, NW, Loftus, J and Ben-Jonathan, N (2011) Dopamine receptors in human adipocytes: expression and functions. PLoS ONE 6, e25537.
Camell, CD, Sander, J, Spadaro, O, Lee, A, Nguyen, KY, Wing, A, Goldberg, EL, Youm, YH, Brown, CW, Elsworth, J, Rodeheffer, MS, Schultze, JL and Dixit, VD (2017) Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature 550, 119–123.
Delgado, I, Huet, L, Dexpert, S, Beau, C, Forestier, D, Ledaguenel, P, Aubert, A, Sauvant, J, Aouizerate, B, Magne, E and Capuron, L (2018) Depressive symptoms in obesity: relative contribution of low-grade inflammation and metabolic health. Psychoneuroendocrinology 91, 55–61.
Flierl, MA, Rittirsch, D, Huber-Lang, M, Sarma, JV and Ward, PA (2008) Catecholamines – crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening Pandora's box? Molecular Medicine 14, 195–204.
Hotamisligil, GS (2017) Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177–185.
Lamers, F, Milaneschi, Y, de Jonge, P, Giltay, EJ and Penninx, BWJH (2018) Metabolic and inflammatory markers: associations with individual depressive symptoms. Psychological Medicine 48, 1102–1110.
Lasselin, J and Capuron, L (2014) Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms. Neuroimmunomodulation 21, 95–101.
Leite, F, Leite, Â, Santos, A, Lima, M, Barbosa, J, Cosentino, M and Ribeiro, L (2017 a) Predictors of subclinical inflammatory obesity: plasma levels of leptin, very low-density lipoprotein cholesterol and CD14 expression of CD16+ monocytes. Obesity Facts 10, 308–322.
Leite, F, Lima, M, Marino, F, Cosentino, M and Ribeiro, L (2016) Dopaminergic receptors and tyrosine hydroxylase expression in peripheral blood mononuclear cells: a distinct pattern in central obesity. PLoS ONE 11, e0147483.
Leite, F, Lima, M, Marino, F, Cosentino, M and Ribeiro, L (2017 b) Β2 adrenoceptors are under expressed in peripheral blood mononuclear cells and associated with a better metabolic profile in central obesity. International Journal of Medical Sciences 14, 853–861.
Marino, F and Cosentino, M (2013) Adrenergic modulation of immune cells: an update. Amino Acids 45, 55–71.
Milaneschi, Y, Lamers, F, Peyrot, WJ, Baune, BT, Breen, G, Dehghan, A, Forstner, AJ, Grabe, HJ, Homuth, G, Kan, C, Lewis, C, Mullins, N, Nauck, M, Pistis, G, Preisig, M, Rivera, M, Rietschel, M, Streit, F, Strohmaier, J, Teumer, A, Van der Auwera, S, Wray, NR, Boomsma, DI, Penninx, BWJH and CHARGE Inflammation Working Group and the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2017) Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry 74, 1214–1225.
Pinoli, M, Marino, F and Cosentino, M (2017) Dopaminergic regulation of innate immunity: a review. Journal of Neuroimmune Pharmacology 12, 602–623.
Thaler, B, Hohensinner, PJ, Krychtiuk, KA, Matzneller, P, Koller, L, Brekalo, M, Maurer, G, Huber, K, Zeitlinger, M, Jilma, B, Wojta, J and Speidl, WS (2016) Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Scientific Reports 6, 30162.
Wong, KL, Yeap, WH, Tai, JJ, Ong, SM, Dang, TM and Wong, SC (2012) The three human monocyte subsets: implications for health and disease. Immunologic Research 53, 41–57.
Zhang, HX, Xu, YQ, Li, YY, Lu, MF, Shi, SX, Ji, JL and Wang, LW (2018) Difference in proinflammatory cytokines produced by monocytes between patients with major depressive disorder and healthy controls. Journal of Affective Disorders 234, 305–310.